Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Linaclotide: evidence for its potential use in irritable bowel syndrome and chronic constipation.

Lee N, Wald A.

Core Evid. 2012;7:39-47. doi: 10.2147/CE.S25240. Epub 2012 Jun 25.

2.

A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.

Johnston JM, Shiff SJ, Quigley EM.

Curr Med Res Opin. 2013 Feb;29(2):149-60. doi: 10.1185/03007995.2012.754743. Epub 2012 Dec 20. Review.

PMID:
23198977
3.

The pharmacokinetics, pharmacodynamics, clinical efficacy, safety and tolerability of linaclotide.

Lee N, Wald A.

Expert Opin Drug Metab Toxicol. 2011 May;7(5):651-9. doi: 10.1517/17425255.2011.572875. Epub 2011 Mar 30. Review.

PMID:
21446888
4.

Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome.

Love BL, Johnson A, Smith LS.

Am J Health Syst Pharm. 2014 Jul 1;71(13):1081-91. doi: 10.2146/ajhp130575. Review.

PMID:
24939497
5.

Linaclotide, novel therapy for the treatment of chronic idiopathic constipation and constipation-predominant irritable bowel syndrome.

Vazquez-Roque MI, Bouras EP.

Adv Ther. 2013 Mar;30(3):203-11. doi: 10.1007/s12325-013-0012-9. Epub 2013 Feb 20. Review.

PMID:
23436110
6.

Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report.

Rey E, Mearin F, Alcedo J, Ciriza C, Delgado-Aros S, Freitas T, Mascarenhas M, Mínguez M, Santos J, Serra J.

Adv Ther. 2017 Mar;34(3):587-598. doi: 10.1007/s12325-016-0473-8. Epub 2017 Jan 12. Review.

7.

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.

Evans BW, Clark WK, Moore DJ, Whorwell PJ.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003960. Review.

PMID:
17943807
8.

Linaclotide: a novel compound for the treatment of irritable bowel syndrome with constipation.

Rothstein RD, Friedenberg FK.

Expert Opin Pharmacother. 2013 Oct;14(15):2125-32. doi: 10.1517/14656566.2013.833605. Epub 2013 Sep 5. Review.

PMID:
24007408
9.

[New therapeutical approaches for treatment of irritable bowel syndrome].

Siegert F, Nieber K.

Med Monatsschr Pharm. 2010 Aug;33(8):285-92; quiz 293-4. Review. German.

PMID:
21189648
10.

Effect of linaclotide in irritable bowel syndrome with constipation (IBS-C): a systematic review and meta-analysis.

Atluri DK, Chandar AK, Bharucha AE, Falck-Ytter Y.

Neurogastroenterol Motil. 2014 Apr;26(4):499-509. doi: 10.1111/nmo.12292. Epub 2013 Dec 18. Review.

PMID:
24351035
11.

Linaclotide: a novel approach to the treatment of irritable bowel syndrome.

Wensel TM, Luthin DR.

Ann Pharmacother. 2011 Dec;45(12):1535-43. doi: 10.1345/aph.1Q428. Epub 2011 Nov 1. Review.

PMID:
22045908
12.

Linaclotide: a new option for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation in adults.

Parker CH, Yuan Y, Liu LW.

Clin Med Insights Gastroenterol. 2013 Jul 31;6:21-32. doi: 10.4137/CGast.S10550. eCollection 2013. Review.

13.

Emerging receptor target in the pharmacotherapy of irritable bowel syndrome with constipation.

Blackshaw LA, Brierley SM.

Expert Rev Gastroenterol Hepatol. 2013 Jul;7(5 Suppl 1):15-9. doi: 10.1586/17474124.2013.820045. Review.

PMID:
23859756
14.

Review article: Linaclotide for the management of irritable bowel syndrome with constipation.

Layer P, Stanghellini V.

Aliment Pharmacol Ther. 2014 Feb;39(4):371-84. doi: 10.1111/apt.12604. Epub 2014 Jan 16. Review.

15.

Linaclotide: a review of its use in the treatment of irritable bowel syndrome with constipation.

McCormack PL.

Drugs. 2014 Jan;74(1):53-60. doi: 10.1007/s40265-013-0157-5. Review.

PMID:
24293117
16.

Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation.

Vazquez Roque M, Camilleri M.

Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):301-10. doi: 10.1586/egh.11.30. Review.

PMID:
21651347
17.

Tegaserod for the treatment of irritable bowel syndrome.

Evans BW, Clark WK, Moore DJ, Whorwell PJ.

Cochrane Database Syst Rev. 2004;(1):CD003960. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD003960.

PMID:
14974049
18.

New treatment targets for the management of irritable bowel syndrome.

Rao S, Weber HC.

Curr Opin Endocrinol Diabetes Obes. 2014 Feb;21(1):9-14. doi: 10.1097/MED.0000000000000034. Review.

PMID:
24300740
19.

Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide.

Yu SW, Rao SS.

Therap Adv Gastroenterol. 2014 Sep;7(5):193-205. doi: 10.1177/1756283X14537882. Review.

20.

Pharmacologic therapy for the irritable bowel syndrome.

Talley NJ.

Am J Gastroenterol. 2003 Apr;98(4):750-8. Review.

PMID:
12738451

Supplemental Content

Support Center